EORTC & Alliance Boots join forces to support a pan-European biobank for research in advanced colorectal cancer
8 Mar 2012
EORTC Biobanking Project
About the Biobanking Project
- The EORTC aims to create Europe’s first Biobank for the study of colorectal cancers.
- This is a unique scientific pan-European initiative, building on the mapping of the human genome.
- The Biobank will be a leading force in the new phase of progress in cancer treatment.
“The EORTC needs to make this biobank a reality to help patients, present and future, who suffer from cancer.”
A Pan-European Partnership
The EORTC Charitable Trust and Alliance Boots are working to:
- Raise 5 million euros over the next 5 years
- Create a Biobank for Colorectal Cancer Tissues
- Set up a DNA Biobank
Related News
EORTC: Advancing research and treatment for rare cancers
29 Feb 2024
EORTC Fellowship Programme: celebrating more than 20 years of impactful collaboration
22 Feb 2024
Appointment of Malte Peters as EORTC Strategic Alliance Officer
9 Feb 2024
Unique series of workshops in partnership with the European Medicines Agency (EMA)
7 Feb 2024
EORTC launches a prominent clinical trial in older patients with locally advanced (LA) HNSCC (Head and Neck Squamous Cell Carcinoma)
14 Dec 2023
Seven IMMUcan abstracts selected for ESMO Immuno-Oncology Congress 2023
6 Dec 2023
EORTC Quality of Life measures integrated in CDISC
20 Nov 2023
EORTC and Immunocore are collaborating to launch the ATOM clinical trial of tebentafusp in Adjuvant Uveal Melanoma
7 Nov 2023
Treatment with decitabine resulted in a similar survival and fewer adverse events compared with conventional chemotherapy in older fit patients with acute myeloid leukaemia
31 Oct 2023
New results and forthcoming EORTC trials in rare cancers, lung, head and neck, and breast carcinomas presented at ESMO 2023
20 Oct 2023